Sharing secrets: Oxytocin and trust in schizophrenia
- 25 June 2009
- journal article
- Published by Informa UK Limited in Social Neuroscience
- Vol. 4 (4), 287-293
- https://doi.org/10.1080/17470910802319710
Abstract
Previous studies indicated that oxytocin plays an important role in human trust, which is impaired in patients with severe mental disorders. In this study, we measured plasma oxytocin levels in patients with schizophrenia (n=50) and in healthy controls (n=50) after neutral and trust-related interpersonal interactions. Trust-related interactions were associated with increased oxytocin levels in controls. This effect was absent in patients with schizophrenia. Low oxytocin levels measured after trust-related interactions significantly predicted the negative symptoms of schizophrenia but were not related to positive symptoms, depression, anxiety, and neuropsychological functions. These results suggest that decreased trust-related oxytocin release is related to the negative symptoms and may be associated with social withdrawal, isolation, and flattened affect in schizophrenia.Keywords
This publication has 32 references indexed in Scilit:
- Stress and the Hypothalamic Pituitary Adrenal Axis in the Developmental Course of SchizophreniaAnnual Review of Clinical Psychology, 2008
- Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficitsSchizophrenia Research, 2008
- Attachment, aggression and affiliation: The role of oxytocin in female social behaviorBiological Psychology, 2007
- Stress and psychosis: Towards the development of new models of investigationClinical Psychology Review, 2007
- RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settingsSchizophrenia Research, 2007
- Oxytocin increases trust in humansNature, 2005
- Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status*1Schizophrenia Research, 2004
- Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medicationSchizophrenia Research, 1994
- Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenicsPsychoneuroendocrinology, 1992
- Studies in the relationship between depressive disorders and anxiety states: Part 1. Rating scalesJournal of Affective Disorders, 1982